Cargando…
Investigating microRNA Profiles in Prostate Cancer Bone Metastases and Functional Effects of microRNA-23c and microRNA-4328
SIMPLE SUMMARY: Bone metastatic prostate cancer is a lethal disease, and improved treatment strategies are urgently needed. MicroRNAs (miRNAs) are short non-coding RNAs with therapeutic possibilities in cancer. The current study compared levels of 1510 miRNAs in prostate cancer bone metastases with...
Autores principales: | Järemo, Helena, Semenas, Julius, Bergström, Sofia Halin, Lundholm, Marie, Thysell, Elin, Widmark, Anders, Crnalic, Sead, Ylitalo, Erik Bovinder, Bergh, Anders, Brattsand, Maria, Wikström, Pernilla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177411/ https://www.ncbi.nlm.nih.gov/pubmed/37173903 http://dx.doi.org/10.3390/cancers15092437 |
Ejemplares similares
-
Characterization of Prostate Cancer Bone Metastases According to Expression Levels of Steroidogenic Enzymes and Androgen Receptor Splice Variants
por: Jernberg, Emma, et al.
Publicado: (2013) -
A novel DNA methylation signature is associated with androgen receptor activity and patient prognosis in bone metastatic prostate cancer
por: Ylitalo, Erik Bovinder, et al.
Publicado: (2021) -
Bone Cell Activity in Clinical Prostate Cancer Bone Metastasis and Its Inverse Relation to Tumor Cell Androgen Receptor Activity
por: Nordstrand, Annika, et al.
Publicado: (2018) -
Marked response to cabazitaxel in prostate cancer xenografts expressing androgen receptor variant 7 and reversion of acquired resistance by anti‐androgens
por: Ylitalo, Erik Bovinder, et al.
Publicado: (2019) -
Epithelial and Stromal Characteristics of Primary Tumors Predict the Bone Metastatic Subtype of Prostate Cancer and Patient Survival after Androgen-Deprivation Therapy
por: Wikström, Pernilla, et al.
Publicado: (2022)